Clofarex clofarabine: Phase II started

BIV began a pivotal U.K. Phase II trial in 65 patients. Clofarabine has Orphan Drug designation in Europe to treat AML and acute lymphoblastic leukemia (ALL), and is under FDA review for relapsed or r...